China Drug Distributor Sinopharm Seeks $1.3 Billion For Market Expansion
This article was originally published in PharmAsia News
Executive Summary
China's largest drug distributor, Sinopharm Group, plans to expand its presence in the nation's health-care market ahead of a predicted tripled growth by the end of the decade.